JanOne Inc. (JAN)


0.00 (0.00%)
Symbol JAN
Price $2.14
Beta 1.797
Volume Avg. 0.07M
Market Cap 6.741M
Shares () -
52 Week Range 1.89-7.13
1y Target Est -
DCF Unlevered JAN DCF ->
DCF Levered JAN LDCF ->
ROE 332.52% Strong Buy
ROA -40656.68% Strong Sell
Operating Margin -
Debt / Equity 755.16% Strong Buy
P/E -
P/B 2,094.93 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest JAN news

Mr. Tony Isaac
Waste Management
NASDAQ Capital Market

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.